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Abstract.  Different fibronectin (FN) variants arise 
from the single gene transcript alternatively spliced in 
a tissue-specific manner (Hynes, R. O.  1985. Annu. 
Rev.  Cell Biol.  1:67-90; Owens, R. J., A.  R. Korn- 
blihtt,  and E  E.  Baralle.  1986.  Oxfi Surv. Eurcaryotic 
Genes.  3:141-160).  We used mAb IST-9,  specific for 
extra domain A  (ED-A) FN sequence, and cDNA 
probe to ED-A exon to determine whether ED-A is 
present in FN synthesized by vascular smooth muscle 
cells (SMCs) and,  if so, whether expression of ED-A 
is SMC phenotype dependent.  ED-A-containing  FN 
(A-FN) was not revealed in tunica media of human ar- 
teries and normal rat aorta by immunofluorescence and 
immunoblotting techniques.  A  eDNA probe to ED-A 
exon did not hybridize with RNA isolated from human 
aortic media.  A  positive reaction with IST-9  was ob- 
served in (a) diffuse intimal  thickening and 
atherosclerotic plaque from human arteries;  (b) ex- 
perimentally induced intimal thickening  in rat aorta; 
and (c) cultured vascular SMCs. A-FN mRNA was 
present in the RNA preparation  from human aortic in- 
tima as judged by hybridization with eDNA probe to 
ED-A. 
On the other hand,  an mAb interacting  with an epi- 
tope common for all FN variants revealed FN in both 
intima and media of human arteries and in the normal 
rat aorta.  A  eDNA probe to a  sequence shared by all 
FN variants hybridized with RNA from both intima 
and media of human aorta,  though the level of expres- 
sion was higher in intima.  The data suggest that ED-A 
exon is omitted during  splicing of the FN mRNA 
precursor in medial SMCs while the expression of 
A-FN is characteristic of "modulated" SMCs-those of 
intimal thickenings,  of atherosclerotic lesions, and 
growing in culture. 
F 
IBRONECTINS (FNs) ~  are high molecular weight gly- 
copmteins playing an important role in different cellu- 
lar phenomena-e.g.,  adhesion, migration,  and dif- 
ferentiation-and, thereby, in embryogenesis, wound healing, 
hemostasis,  and thrombosis (26, 35, 61). The FN molecule 
is a dimer with a subunit mass of ,x,250,000 D. The primary 
structure of FN has been studied both on protein (human and 
bovine FN) and cDNA (chicken,  rat, and human FN) levels 
(7, 16-18, 32, 38, 42, 45, 50, 53, 55). The FN subunit is com- 
posed of three different kinds of repeating sequences (32, 45, 
53).  Two fibrin-binding  domains,  NH2 and COOH termi- 
nal, and a collagen-binding domain,  NH2 terminal,  are made 
up of 45-5G--amino acid-long repeats types I and II, while 
a 90-amino acid-long repeat type HI composes the central 
150,000-180,000-D part of the FN subunit (45, 53). Subtle 
alterations  in subunits  give rise to various FN forms.  Cir- 
1. Abbreviations  used in this paper: A-FN, fibronectin containing extra do- 
main A sequence; cFN, cellular fibronectin; ED-A, extra domain A; ED-A- 
FN, fibronectin that lacks ED-A; FN, fibronectin; pFN, plasma fibronectin; 
SM,  smooth muscle; SMC, smooth muscle cell. 
culating form, or plasma FN (pFN), is synthesized by hepa- 
tocytes; fibroblasts,  endothelial  cells, and some other cells 
produce cellular FN (cFN), which is accumulated in the in- 
soluble extracellular matrix (6, 43, 52, 54, 57). pFN was also 
shown to penetrate from circulation  into the tissue and to be 
incorporated in the extracellular  matrix (39). 
The differences  in the primary structures  of FN synthe- 
sized by various  cells are the results  of alternative  splicing 
of the RNA transcript  of the single  FN gene (25, 41). Se- 
quence  variations  can  occur  in  three  points  of the  FN 
subunit:  extra domains A and B (ED-A and ED-B, respec- 
tively) and IIICS in human FN; and EIIIA, EIIIB, and Y in 
the rat protein (23, 25, 41, 51, 62). The two former sequehces 
are either omitted or included, while the latter one varies in 
length,  if present.  ED-A and ED-B exons were not detected 
in liver mRNA, and the corresponding peptides are absent 
in pFN; however, ED-A and ED-B were identified in mRNA 
from fibroblasts  and several other cell lines  (6,  13, 30-32, 
43, 5!, 54, 57). Thus,  ED-A and ED-B sequences code for 
unique domains of cFN. 
The  microheterogeneity  of FN synthesized  by different 
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probes but also with antibodies recognizing certain FN se- 
quences (6,  8-10,  44,  57).  mAb  IST-9,  described earlier, 
recognizes the ED-A fragment of human FN and, therefore, 
reacts with cFN rather than pFN (6, 8). The ED-A sequence 
corresponds to a 270-nucleotide exon coding for one unit of 
repeat type III (58). We used IST-9 and the cDNA probe for 
the ED-A sequence to reveal ED-A-containing FN (A-FN) 
and  the corresponding mRNA  in vascular smooth muscle 
cells (SMCs). 
The  mature  mammalian  artery  wall  consists  of  three 
layers: tunica intima, tunica media, and tunica adventitia (46). 
In the infant human aorta, as well as in the normal adult aorta 
of the majority of the mammals, tunica intima appears to be 
rather thin, consists of only endothelial monolayer and un- 
derlying basement membrane, and does not contain SMCs. 
On the contrary, in the grossly normal segments of the adult 
human arteries (aorta, carotid, iliac arteries, etc.) a diffuse 
intimal thickening is always found. The major cell type in 
this layer as well as in tunica media is smooth muscle (SM) 
(46).  Atherosclerotic lesions basically involve only the in- 
timal layer of the arteries. 
SMCs both in  situ and  in culture are known to express 
phenotypes that represent various differentiation states (ll, 
14, 36, 49). The cytoplasm of differentiated or "contractile" 
SMCs is packed with myofilaments and contains very little 
mitochondria, rough endoplasmic reticulum, free ribosome, 
etc. In "synthetic" or "modulated" SMCs, the organelles are 
quite numerous while contractile elements are reduced. Syn- 
thetic cells produce and secrete a lot of extracellular matrix 
material.  SMCs from atherosclerotic lesions of human ar- 
teries, as well as those from experimental intimal thickening 
in  animal  arteries,  express the  synthetic or fibroblast-like 
phenotype (14, 37, 48, 49). In the tunica media of mature ar- 
teries, SMCs are in the contractile state,  but they undergo a 
spontaneous change in phenotype (phenotypic modulation) 
if they are isolated from the tissue by enzyme treatment and 
seeded into culture. Here we use the term modulated to de- 
scribe an SMC phenotype altered, at least partly, from that of 
differentiated medial SMCs. It is well known that modulated 
SMCs  may  retain  some  characteristics  of the  contractile 
phenotype.  For  instance,  alpha-SM-actin  is  expressed  in 
SMCs proliferating in culture (40); and subendothelial in- 
timal cells, which were shown to contain decreased amounts 
of the SM markers gamma-vinculin, meta-vinculin, and 150- 
kD caldesmon have an isoactin pattern typical of contractile 
vascular SMCs (4, 20). 
Both the level of FN gene transcription and the pattern of 
FN mRNA splicing were shown to be altered in response to 
physiological stimuli-exposure to growth factors-and on 
transformation (1, 5, 6,  10, 27, 51). Therefore, we have sug- 
gested that the changes expressed in the spectrum of FN vari- 
ants may be associated with SMC phenotypic modulation. 
The aim of this study was to determine whether the ED-A 
sequence specific for cFN is present in FN synthesized by 
vascular SMCs and, if so, whether the expression of ED-A 
is SMC phenotype dependent. We were able to demonstrate 
that A-FN is synthesized by modulated rather than contrac- 
tile vascular SMCs. 
Materials and Methods 
mAbs 
mAbs IST-9 and IST-4 to human FN (6, 8, 52) were a generous girl of Dr. 
L. Zardi (Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy). IST-9 
recognizes the ED-A sequence present only in cFN; IST-4 interacts with an 
epitope that is located within the first four type III homology repeats and 
shared by different FN subunit variants (52). Undiluted culture supernatants 
were used for both immunofluorescence and immunobloUing. Mouse mAb 
4.29.AB raised against human pFN and cross reacting with different mam- 
malian FN was kindly provided by Dr.  M.  Chemousov (Institute of Ex- 
perimental Cardiology, Cardiology Research Center, Moscow, USSR). For 
staining of rat aorta sections ascites fluid was diluted 1:100. 
mAb IIG10,  raised against cultured human aortic SMCs, recognizes a 
surface antigen of SMCs and fibroblasts; endothelial cells, macrophages/ 
monocytes, peripheral blood lymphocytes, etc., were shown to be IIG10 
negative (19).  The IgM fraction purified from ascites fluid was diluted to 
50 #g/ml for immunostaining. 
Figure 1. Indirect immunofluorescence staining of 3-mo-old human child thoracic aorta serial sections with anti-FN mAb. (a) mAb IST-9 
(A-FN); (b) mAb IST-4 (total FN).  Bar,  l0/~m. 
The Journal  of Cell Biology,  Volume 109, 1989  358 Figure 2. Indirect  immunofluorescence  staining of human adult aortic intima and media sections with anti-FN mAb.  (a and b) Diffuse 
intimal thickening;  (c and d) media.  (a and c) mAb IST-9 (A-FN);  (b and d) mAb IST-4 (total FN). Bars, 20 #m. 
Human Tissue Samples 
Human artery  samples were obtained at autopsies taken within 4-6 h of 
death.  For immunoblotting analysis, arteries  were opened; adventitia was 
discarded; endothelium was removed mechanically; and intima and media 
were separated, frozen in liquid nitrogen, minced, and dispersed in Laemmli 
sample buffer (33). For immunofluorescence, segments of the arteries were 
dropped into freezing isopentane, and 5-#m cryostat sections were cut. 
Balloon Injury Model 
Male Wistar rats (350-400 g) were used in the experiments. Balloon injury 
of  the aorta was performed via left carotid artery according to a modification 
(22) of the method originally developed by Baumgartner (3). The animals 
were killed on day 14, and thoracic aortas were dissected, washed in DME, 
frozen, and cut into 5-/zm cryostat sections. 
Cell Culture 
SMCs  from  media  and  intima  of human  aorta  were  isolated  by  col- 
lagenase-elastase  digestion of the tissue (l 1), and cultured in DME (Flow 
Laboratories,  Inc.,  McLean,  VA) supplemented with  10 mM Hepes,  100 
/zg/ml sodium piruvate, 50/~g/ml ascorbic acid, 0.6 mg/ml L-glutamine, 50 
/~g/ml gentamicin sulfate, and  10% heat-inactivated human serum.  In the 
primary culture >90% of intimai and medial ceils were stained with anti- 
SM-actin antibody, CGA-7, kindly provided by Dr. Allen M. Gown (Depart- 
ment of Pathology, University of Washington, Seattle, WA). 
Immunofluorescence and Immunoblotting 
For immunofluorescence, frozen sections were fixed in absolute acetone for 
5 min at room temperature. SMCs growing on the coverslips were washed 
in PBS, fixed with 4% paraformaldehyde, and again washed in PBS. Fixed 
sections or cells were incubated with primary  antibodies for 1 h at room 
temperature,  washed  in  PBS  for  30  min,  incubated  with  FITC-rabbit 
anti-mouse IgG (Miles Scientific Die., Naperville, IL) diluted 1:40 for 45 
min, thoroughly washed, air dried, and mounted in UV-inert embedding 
medium (Serva Fine Biochemicals Inc., Garden City Park, NY). Specimens 
were observed with a microscope (E. Leitz, Inc., Wetzlar, FRG) using 25- 
and 16x objectives. Photographs were taken with Tri-X film (Eastman Ko- 
dak Co., Rochester, NY). 
Immunoblotting was performed according to the method of Towbin et al. 
(56).  z2SI-Labeled rabbit  anti-mouse IgG  (2  ~g/ml,  sp act 0.5  x  106 
cpm/ftg) was used as a secondary antibody. 
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aortic intima and media. (a) SDS-PAGE  (5-15%) of  the human aor- 
tic intimal and medial extracts, Coomassie blue-stained gel. (b and 
c) Autoradiographs of the immunoblots done with mAb IST-4 (b), 
recognizing total FN, and IST-9 (c), recognizing A-FN. (Lane l) 
Intimal extract; (lane 2) medial extract; (lane 3) purified pFN. A, 
actin; FN, fibronectin. The loading for immunoblotting for intimal 
extract (b and c, lanes 1) was the same as in a, for medial extract: 
five times as much as in a, lane 2. 
RNA Extraction and Hybridization 
Separated intima and media of human aorta were homogenized in guanidine 
thiocyanate  lysis buffer (6 M guanidine thiocyanate,  0.2  M Tris-HCl, pH 
7.5, 2 mM EDTA, 1 mM/3-mercaptoethanol,  1% N-laurylsarkosin)  followed 
by phenol extraction (12). For dot hybridization, denaturated RNA was diluted 
in 10 mM Tris-HC1, pH 7.6, to achieve the desired concentration, and im- 
mobilized on a Z-probe blotting membrane (Bio-Rad Laboratories, Richmond, 
CA) using Minifold apparatus (Schleicher & Schuell, Inc., Keene, NH). The 
membranes were baked and prehybridized for at least 4 h in buffer contain- 
ing 50% deionized formamide,  1% SDS, 10% Dextran sulfate, 0.25 M Na- 
phosphate, pH 7.5, 0.25 M NaCI, 5 mM EDTA, 0.125% pirophosphate,  I mg/ 
ml heparin, and 0.25 mg/ml of sonicated chicken erythrocyte DNA. Hybrid- 
ization was performed at 50°C for 18-24 h in the same buffer containing the 
appropriate 32p-labeled DNA probe (106 cpm/mi). The filters were washed, 
dried, and exposed  to XAR-5  film (Eastman Kodak Co.) at  -70°C. 
pFH1 probe (29) was kindly provided by Dr. E  E. Baralle and contained 
a 1,700-bp sequence coding for human FN, inserted in pAT153/Pvu II/8 plas- 
mid vector. Plasmid DNA was isolated,  nick translated (47), denatured, and 
used in hybridization  assay. A 173-bp probe to ED-A FN sequence was kind- 
ly provided  by Dr.  L. Zardi and labeled by nick translation. 
Results 
Localization of  A-FN in the Human Artery Wall 
Transverse sections of 3-mo-old human child aorta, which 
had no diffuse intimal thickening, were stained with mAbs 
IST-9, specific for the ED-A region of FN, and IST-4, recog- 
nizing an epitope shared by all FN variants. Data presented 
in Fig.  1 a  show that only the luminal surface of the aorta 
wall was stained with IST-9. The pattern of the staining was 
practically identical to that obtained with the antibody to fac- 
tor VIII, a marker of the endothelial cells (data not shown); 
however, an SM  layer of the wall  (the whole media) was 
negative and, thus, did not contain A-FN. On the other hand, 
in the serial section, IST-4 revealed a significant amount of 
FN (Fig. 1 b). The most intensive fluorescence was concen- 
trated in the juxtaluminal region and, although moderate, it 
was quite obvious in the rest of the wall. The data show that 
only FN that did not contain ED-A (ED-A- FN) was pres- 
ent in the SM layer of the 3-mo-old human child aorta. 
To determine whether A-FN is present in the adult human 
aorta, the transverse sections of the grossly normal segments 
of the aorta (from 45-65-yr-old donors) were stained with 
IST-9.  A positive reaction was observed only in the intima 
(Fig. 2); media did not stain with antibody, and only elastic 
fibers were visible in  Fig.  2  c  because of their intensive 
autofluorescence. 
The antigenic determinant recognized by IST-9 could be 
masked in the media by the tissue components. Therefore, 
SDS extracts of separated media and intima were analyzed 
by immunoblotting (Fig. 3). The content of FN in the intimal 
extract was obviously higher than in the medial; therefore, 
to make total FN loading in both extracts similar, the amount 
of medial extract applied to the gel was approximately five 
times greater than that of intimal, as judged by actin content 
(see Fig. 3 a). Nevertheless, A-FN was found only in the in- 
tima, while the media contained only traces of IST-9-posi- 
tive material, if any (Fig.  3 c). 
In atherosclerotic fibrous plaque from the human iliac ar- 
tery, media also did not contain A-FN while intima stained 
with mAb IST-9; both of the layers contained FN, as was re- 
vealed by mAb IST-4 (Fig. 4). SMCs in the intima and media 
were stained with mAb IIG10. 
Identification of  ED-A Sequence in the mRNA from 
Human Aorta 
To determine whether  A-FN  mRNA  species  were  repre- 
sented in mRNA from human aorta, a eDNA probe to ED-A 
sequence was hybridized with total RNA prepared from the 
media and subendothelial intima of  human adult aorta. To re- 
veal total FN mRNA, a eDNA probe to the sequence present 
in all FN subunit types was used. The data shown in Fig. 5 
demonstrate that FN mRNA was present in RNA prepara- 
tions from both intima and media, and that the amount of 
ED-A-containing species  was  almost negligible in  medial 
RNA  and  rather high in  intimal  RNA.  Notably, total FN 
mRNA content in intimal RNA preparations was three- to 
fivefold higher compared with medial RNA. 
A-FN in the ExtraceUular Matrix of Cultured SMCs 
from Intima and Media of  Human Adult Aorta 
SMCs were isolated by enzyme digestion of the separated 
media and intima of human adult aorta, seeded into culture, 
and on days 5 and 14 stained with mAb IST-9 to reveal A-FN. 
Medial as well as intimal SMCs secreted A-FN, which was 
already visible on the cell surface on the fifth day of cultiva- 
tion,  being incorporated in the characteristic extracellular 
matrix  network  (Fig.  6).  Northern  blot  analysis  demon- 
strated the presence of ED-A sequence in RNA preparation 
from cultured medial SMCs (data not shown). 
Identification of  A-FN in the Experimental lntimal 
Thickening in the Rat Aorta 
In the normal rat aorta wall only the endothelial lining was 
The Journal of Cell Biology, Volume 109, 1989  360 Figure 4. Serial sections showing indirect immunofluorescence staining of atherosclerotic plaque from human iliac artery. (a) mAb IST-9 
(A-FN); (b) mAb IST-4 (total FN); (c) mAb IIG10 (SMC surface antigen); (d) negative control (section was incubated with PBS instead 
of the primary antibody).  Bar, 20/~m. 
stained with IST-9; the SM layer was negative (Fig. 7). The 
whole media was stained with mAb 4.29.AB, which interacts 
with an epitope present in all FN types, mAb IST-4 could not 
be used in these experiments since it did not cross react with 
rat FN. In the neointima, which was formed in the aorta as 
a response to endothelial injury with a balloon catheter, mAb 
IST-9 revealed A-FN; the underlying media remained IST-9 
negative.  Thus,  only ED-A-negative FN  (ED-A- FN)  was 
present in the SM layer of the normal rat aorta, while in the 
experimental intimal thickening  A-FN was found. 
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preparation from human aortic intima and media, cDNA probe to 
ED-A exon of human FN (a) and pFH 1 probe to human FN (b) 
were hybridized with total RNA isolated from media (1) and intima 
(2) of  human aorta. RNA amount in the initial point, 10/~g; dilution 
factor, 2. 
Discussion 
Expression of  A-FN Is Characteristic of  Modulated 
Rather Than Contractile Vascular SMCs 
We have shown that tunica media of the arteries did not con- 
tain A-FN and that ED-A-containing mRNA species were 
practically absent in the RNA samples from media. On the 
contrary, in the diffuse intimal thickening of  the adult human 
aorta, as well as in atherosclerotic fibrous plaque, the content 
of A-FN was  rather high and the ED-A sequence was re- 
vealed in the RNA prepared from human adult aortic intima. 
It is well established that the expression of differentiated 
SMC  phenotype  characteristics  is  altered  in  the  intimal 
thickenings of human and animal arteries and in atheroscle- 
rotic lesions (2, 4, 15, 20, 28, 34, 36, 59, 60). At birth, sub- 
endothelial intima of human aorta usually consists of only a 
thin connective tissue layer which does not contain SMCs. 
With aging, intima becomes progressively thickened as SMCs 
of  the subjacent layers migrate to the intima, proliferate, syn- 
thesize, and secrete extracellular matrix components. In the 
3-mo-old human child aorta, A-FN was found only at the lu- 
minal surface rather than in SM layer. On the contrary, by 
analyzing an  ll-yr-old human child aorta we were able to 
identify minor intimal thickenings which were all IST-9 posi- 
tive and, thus, contained A-FN (not shown). In the arteries 
of the adult donors (45-60 yr old), A-FN was always found 
in the thickened intima regardless of the presence of athero- 
sclerotic lesions. Also, cultured medial, as well as intimal, 
SMCs secrete A-FN which is incorporated into extracellular 
matrix network. Therefore, we conclude that the expression 
of A-FN is associated with the synthetic or modulated rather 
than contractile SMC phenotype. 
It should be mentioned that besides SMCs,  some blood- 
borne cells, particularly monocytes/macrophages, might be 
present in intima, especially in its preluminal part. However, 
even if present, these cells would not contribute appreciably 
to the production of A-FN in the intima because of their ex- 
tremely low density. Recently we have shown that isoactin 
pattern of the cells from diffuse intimal thickening was iden- 
tical to that of medial cells (4, 20) and, therefore, it can be 
concluded that the vast majority of intimal cells are of SM 
origin. On the other hand Gown et al. have demonstrated that 
SMCs are a predominant cell type present in the atheroscle- 
rotic fibrous plaque (21). 
Phenotypic Changes of  SMCs Are Accompanied by the 
Changes of  FN mRNA Splicing Pattern 
Medial SMCs are known to undergo a phenotypic transition 
in primary culture. In the animal arteries in vivo, phenotypic 
modulation occurs when endothelial integrity is disturbed by 
a  balloon catheter-contractile medial SMCs become acti- 
vated, migrate to the intima, proliferate, and form intimal 
thickening. We were able to demonstrate that in both cases 
the transition from a contractile to a synthetic state was ac- 
companied by the A-FN accumulation and, since the RNA 
preparation from the human aortic media did not contain the 
ED-A sequence, by the alteration of the FN mRNA splicing 
pattern. The data suggest that the FN mRNA splicing pattern 
is controlled not only in the tissue-specific manner, but can 
be altered in the SMCs in response to physiological stimuli 
that cause phenotypic modulation. Recently, the cell type- 
specific fashion of alternative splicing of the rat and human 
FN gene transcript was shown to be a subject for modulation 
also during transformation (1, 6,  10, 51). 
SMC phenotype modulation, observed as a response to the 
endothelium injury, is associated with cell migration-i.e., 
with the changes of  the cell-matrix interaction involving nec- 
tins and integrins. Phenotypic modulation of the SMC iso- 
lated by the enzyme digestion of media begins only when 
the cell is well adhered to the surface and spread. Hedin et 
al. have shown that SMCs lose contractile phenotype very 
rapidly if seeded onto a FN-coated surface, but rather slowly 
if laminin is used as a coating protein (24). FN provides bet- 
ter adhesion and spreading for SMCs than laminin does. In 
the process of adhesion, cell-extrac'ellular matrix linkages 
are formed that may dramatically differ from those in the tis- 
sue. Thus, not  just the exposure to the growth factors but also 
the alteration of  the cell-matrix interrelationship might serve 
as  a  signal  to the cascade events that  lead to phenotypic 
modulation: (a) reduction and even loss of SM-characteristic 
contractile and cytoskeletal proteins; (b) an increase of ex- 
tracellular matrix component production and secretion and 
(c), as we demonstrate here, the expression and accumula- 
tion  of A-FN  (i.e.,  the  alteration  of FN  mRNA  splicing 
pattern). 
Only ED-A- FN Is Expressed in Contractile 
Vascular SMCs 
The presence of mRNA encoding FN in the RNA prepara- 
tion from media, as well as a significant amount of FN found 
in the media of the aorta and iliac artery, prove that the local 
synthesis of FN exists and, since A-FN was not found in the 
media, 0nly ED-A- species are synthesized. Earlier, hepa- 
The Journal of Cell Biology,  Volume 109, 1989  362 Figure 6. Indirect immunofluorescence staining of cultured SMCs from the intima and media of human aorta with mAb IST-9. (a and b) 
5 d of cultivation;  (c and d)  14 d of cultivation.  (a and c) Medial cells;  (b and d) intimal cells.  Bar, 3/~m. 
tocytes were shown to produce exclusively ED-A- FN and, 
therefore, to be a  source of pFN.  Our data suggest that at 
least a  part of the  circulating  ED-A-  FN  might originate 
from vascular SMCs. 
It should be mentioned that the absence of A-FN in the me- 
dia may be a result of (a) a decreased stability of the protein 
and/or corresponding mRNA; or (b) an alteration of the FN 
mRNA splicing pattern. The first possibility seems unlikely 
since  ED-A-containing  mRNA was  not  detected  in  RNA 
preparation from media. 
Although A-FN is present in the intima, it is not yet clear 
whether it is the only FN variant synthesized locally since 
ED-A- FN might be expressed in the intimal layer as well. 
It seems important to study the pattern of FN variants synthe- 
Glukhova ct al. Expression of Extra Domain A  Fibronectin  Sequence  363 Figure 7. Indirect immunofluorescence staining of rat aorta sections with anti-FN mAb. (a and b) Normal aorta; (c and d) segments with 
thickened intima. (a and c) mAb IST-9 (A-FN); (b) mAb 4.29.AB (total FN); (d) negative control (section was incubated with PBS instead 
of the primary antibody). Bars, 50 #m. 
sized  by  intimal  and  medial  SMCs  that  express  different 
phenotypes. Besides the antibodies recognizing certain do- 
mains of the FN molecule, cDNA probes to variable regions 
of FN might be a useful tool in such a study, and in situ hy- 
bridization seems  to be a most promising approach. 
In conclusion, we demonstrate here that (a) the FN gene 
is expressed in both medial and intimal SMCs of the human 
arteries,  though the level of expression is higher in intimal 
SMCs; (b) the ED-A exon is always omitted during splicing 
of FN mRNA precursor in medial SMC and, therefore, only 
ED-A- FN is produced by these cells; and (c) the expression 
of A-FN  is  characteristic  of modulated  vascular  SMCs- 
those  of  intimal  thickenings,  atherosclerotic  lesions,  and 
growing in culture. 
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